MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
September 25, 2007
Billy Fisher
Bristol-Myers Buys In to Biologics Looking to advance its biologics strategy, Bristol-Myers Squibb announces it will acquire Adnexus Therapeutics, a privately held developer of biologics. mark for My Articles similar articles
The Motley Fool
November 27, 2006
Billy Fisher
Banner Year for Meridian Bioscience The little diagnostic-test-kit maker that could. The company has seen its stock price appreciate 27% over the past twelve months, and it recently reported a record fiscal 2006. mark for My Articles similar articles
The Motley Fool
January 23, 2007
Billy Fisher
Strong Start at Meridian Bioscience From an earnings standpoint, the Cincinnati-based life science company reported another record quarter, and it should continue to impress onlookers in the months ahead. mark for My Articles similar articles
The Motley Fool
September 24, 2007
Billy Fisher
Getting It Done at Meridian Bioscience Impressive earnings growth and disciplined spending continue to propel this small cap up and up. Investors, take note. mark for My Articles similar articles
The Motley Fool
February 1, 2008
Brian Lawler
AstraZeneca's Trying to Get Healthier Big pharma AstraZeneca tries to get back on track by reducing costs. mark for My Articles similar articles
The Motley Fool
December 20, 2007
Brian Orelli
2007: The Year Pharma Fell in Love With Biologics The reason for pharma's newfound infatuation for biotech is quite clear. Many pharmaceutical companies are facing a patent cliff in the coming years, and they need to replace their blockbusters with something. mark for My Articles similar articles
The Motley Fool
October 26, 2007
Billy Fisher
A Quarter to Boast About at Bristol Bristol-Myers announces a 22% rise in third-quarter revenue as Plavix sales continue to rise. Investors, take note. mark for My Articles similar articles
Chemistry World
April 24, 2007
Victoria Gill
AstraZeneca Scoops up $15.6 Billion Vaccine Business AstraZeneca has joined the race to scoop up acquisition opportunities in the biologics sector with a $15.6 billion deal to buy U.S. vaccines and biotechnology company MedImmune. mark for My Articles similar articles
The Motley Fool
April 24, 2007
Brian Lawler
MedImmune Not Immune to Takeovers MedImmune shops itself to AstraZeneca. MedImmune investors appear to be getting a pretty sweet deal. mark for My Articles similar articles
The Motley Fool
April 20, 2007
Billy Fisher
Feverish Growth at Meridian Bioscience Looking to add a small-cap health-care stock to your portfolio? You might want to carefully consider the recent performance and future prospects of diagnostic-test-kit maker Meridian Bioscience. mark for My Articles similar articles
The Motley Fool
January 26, 2007
Kimberly-Clark Won't Need Tissues This Time: Fool by Numbers The consumer products giant released fourth-quarter 20006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
August 29, 2008
Brian Lawler
Will Biopharma Acquisitions Never Cease? In both the size and quantity of proposed deals, the past 24 months have been busier than ever for biopharma dealmakers. What's behind all this activity? mark for My Articles similar articles
The Motley Fool
February 5, 2007
Billy Fisher
A Fresh Outlook at AstraZeneca Strong performance makes management happy at the European drug giant. As long as the company is able to continue the strong revenue growth from its major contributors, shareholders will be able to enjoy a prosperous 2007. mark for My Articles similar articles
The Motley Fool
June 21, 2007
Relax, It's FedEx: Fool by Numbers The delivery company released fiscal fourth-quarter and full-year 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
January 19, 2007
Anders Bylund
GE Bulks Up: Fool by Numbers The conglomerate released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Management Effectiveness... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
February 28, 2007
Right On, Target: Fool by Numbers The cheap-chic retailer released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
February 22, 2007
PDL Biopharma's Fair Q4: Fool by Numbers The pharmaceutical released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
February 1, 2006
Tim Beyers
Google Gags on Q4 Estimates: Fool by Numbers The company released fourth-quarter and full fiscal 2005 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
June 20, 2007
La-Z-Boy Reclines: Fool by Numbers The furniture maker released fourth-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
March 1, 2007
Point Centerpoint Energy: Fool by Numbers The energy company released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
February 7, 2007
IAC Remains Optimistic: Fool by Numbers The interactive conglomerate released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
June 29, 2007
General Mills' Healthy Start: Fool by Numbers The processed food giant released fourth-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
Pharmaceutical Executive
February 1, 2007
Ben Bonifant et al.
Driven to License The competition for innovative biotech products is intense, giving rise to an unprecedented diversity of partnering strategies and an equally unprecedented convergence of small-molecule drugs and biologics in company portfolios. Licensings are shaping up as the year's big deal. mark for My Articles similar articles
The Motley Fool
January 26, 2007
Enterprise Products Partners: Fool by Numbers The natural gas pipeline operator released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
January 26, 2007
Lockheed Martin Defends the Bottom Line: Fool by Numbers The defense giant released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlight... mark for My Articles similar articles
The Motley Fool
February 20, 2007
Ryan Fuhrmann
Home Depot Needs Improvement: Fool by Numbers The home-improvement giant released fourth-quarter and year-end 2006 results: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
March 23, 2007
Williams-Sonoma Simmers: Fool by Numbers The specialty home products retailer released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
June 8, 2007
Quality Systems Grows On: Fool by Numbers The medical software maker released fourth-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
December 18, 2009
Brian Orelli
Buy a Company, Get the Plant for Free Earlier this year, Merck company bought a pipeline of follow-on biologics (and a manufacturing plant to make them in) from Insmed. Now it's back for more with an acquisition of Avecia Biologics. mark for My Articles similar articles
The Motley Fool
August 18, 2010
Charly Travers & Seth Jayson
Will United Therapeutics Burn You? United Therapeutics is cash flow-positive and has mostly been over the past few years. That's investment nirvana for biotech shareholders. This is a rare beast worthy of additional research. mark for My Articles similar articles
Pharmaceutical Executive
October 1, 2011
Daniel Vasella
Heart of Success: Patient-Centric R&D Drug discovery must remain a core competency of industry. The future success of individual companies will be tightly linked to success in R&D. mark for My Articles similar articles
The Motley Fool
February 16, 2007
Vonage on Hold: Fool by Numbers The broadband telephone service provider released its fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Operating Highlights... mark for My Articles similar articles
The Motley Fool
May 9, 2007
A Clean Look at Steris: Fool by Numbers The medical products maker released fourth-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
March 8, 2007
Talbots All Tucked In: Fool by Numbers The women's clothing retailer released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
February 9, 2007
A Shot of Income for MedImmune: Fool by Numbers The pharmaceutical released earning for the fourth-quarter 2006: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
May 24, 2007
The ABCs of CA: Fool by Numbers The IT management software maker released fourth-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
March 15, 2007
eCollege.com Drops a Class: Fool by Numbers The online educator released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
January 31, 2007
3M's Money Mojo: Fool by Numbers The conglomerate released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
February 1, 2007
L-3 Locked on Target: Fool by Numbers The defense electronics and communications powerhouse released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
February 16, 2007
Ryan Fuhrmann
Buffalo Wild Wings Flies High: Fool by Numbers The hot-wings and sport-bar restaurateur released fourth-quarter and year-end 2006 results: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
January 25, 2007
Check Point Checks In: Fool by Numbers The software maker released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
February 16, 2007
Sales Upswing at Wright Medical: Fool by Numbers The orthopedics player released earnings for the fourth quarter 2006: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
February 2, 2007
Aspiring AstraZeneca: Fool by Numbers The pharmaceutical released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
August 9, 2007
Mike Cianciolo
1-800-Flowers Grows Stronger: Fool by Numbers A quick look at the fourth-quarter results of 1-800-Flowers.com, where the profits, margins, and sales are all growing very nicely. mark for My Articles similar articles
The Motley Fool
March 23, 2007
Stardom for New York & Co.: Fool by Numbers The apparel retailer released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
April 26, 2007
Brian Lawler
AstraZeneca's Announcement Overshadows Earnings AstraZeneca releases first-quarter financial results. Investors, take note. mark for My Articles similar articles
The Motley Fool
February 1, 2007
Google Ogles Profits: Fool by Numbers The search-engine king released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
February 23, 2006
Seth Jayson
Genuine Parts, Bigger Whole: Fool by Numbers The company released fiscal year 2005 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
March 1, 2007
California Water Service Going Swimmingly: Fool by Numbers The water company released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
January 26, 2007
Nucor's Strong as Steel: Fool by Numbers The steel company released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles